Recently, three groups evaluated the effects of monoclonal antibodies, convalescent serum, and vaccines on Delta variant, 1 , 2 , 3 which leads to concerns about the effectiveness of current vaccines to the upcoming SARS-CoV-2 variants. The World Health Organization (WHO) has designated SARS-CoV-2 variants Alpha(B.1.1.7), Beta(B.1.351), Gamma(P.1), and Delta(B.1.617.2) as Variants of Concern (VOC), among which Delta variant with remarkable transmission and immune escape ability has attracted great attentions.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: